iRhythm EVP sells 732 shares under trading plan

iRhythm Holdings, Inc. executive vice president of strategic business operations Mervin Smith reported an open-market sale of common stock.

Rhea-AI Filing Summary

iRhythm Holdings, Inc. executive vice president of strategic business operations Mervin Smith reported an open-market sale of common stock. On February 24, 2026, he sold 732 shares at an average price of $140.91 per share.

After this transaction, Smith directly owned 15,106 shares of iRhythm common stock. The sale was executed under a pre-established Rule 10b5-1 trading plan that Smith adopted on November 19, 2025, indicating the trades were made according to a predetermined schedule.

Insider Trade Summary

Net Seller: 732 shares

Net Sell 1 txn

Insider Smith Mervin

Role EVP Strategic Business Ops

Sold 732 shs ($103K)

Type	Security	Shares	Price	Value
Sale	Common Stock	732	$140.91	$103K

Holdings After Transaction: Common Stock — 15,106 shares (Direct)

Footnotes (1)

1. F1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 19, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did iRhythm (IRTC) executive Mervin Smith report in this Form 4 filing?

Mervin Smith reported an open-market sale of iRhythm common stock. He sold 732 shares at an average price of $140.91 per share, and after the transaction he directly held 15,106 shares, according to the Form 4 disclosure.

How many iRhythm (IRTC) shares did Mervin Smith sell and at what price?

Mervin Smith sold 732 shares of iRhythm common stock. The reported average sale price was $140.91 per share, reflecting an open-market transaction as described in the Form 4 insider trading report filed with the SEC.

How many iRhythm (IRTC) shares does Mervin Smith own after the reported sale?

After the reported transaction, Mervin Smith directly owns 15,106 iRhythm common shares. This post-transaction holding figure is disclosed in the Form 4 and represents his remaining direct ownership following the 732-share open-market sale.

Was the iRhythm (IRTC) insider sale by Mervin Smith under a Rule 10b5-1 plan?

Yes. The Form 4 footnote states the sale was executed under a Rule 10b5-1 trading plan. The plan was established by Mervin Smith on November 19, 2025, indicating the sale followed a pre-arranged trading schedule rather than discretionary timing.

What is Mervin Smith’s role at iRhythm (IRTC) mentioned in the Form 4?

The Form 4 identifies Mervin Smith as an officer of iRhythm with the title “EVP Strategic Business Ops.” This means he serves as executive vice president for strategic business operations while also being a reporting person for insider transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 06:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Mervin

(Last) (First) (Middle)

C/O IRHYTHM HOLDINGS, INC.

699 8TH STREET, #600

(Street)

SAN FRANCISCO CA 94103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
iRhythm Holdings, Inc. [ IRTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP Strategic Business Ops

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026	02/24/2026	S		732(1)	D	$140.91	15,106	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 19, 2025.

Remarks:

On January 12, 2026, iRhythm Technologies, Inc. (iRhythm Tech) and iRhythm Holdings, Inc. (Issuer) effectuated a holding company reorganization pursuant to which the Issuer became the successor issuer to iRhythm Tech pursuant to Rule 12g-3(a) of the Securities Exchange Act of 1934, as amended. On such date, all outstanding shares and equity awards of iRhythm Tech automatically converted into securities of the Issuer on a one for one basis, with no change to the proportionate interests of security holders.

	/s/ Marc Rosenbaum, attorney-in-fact	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.